Dr Eugene Durenard, CEO of Hyperbolic Holdings GmbH discusses promising emerging technologies in the field of early detection and prevention of major chronic diseases.
Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill, writes in detail about plague, the first pandemic disease including comment on bacteria.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, describes the present concern and future therapeutic perspective on Huntington’s disease.
The impact of COVID-19 has proven that we cannot let people with lung conditions continue to be forgotten, says Dr Alison Cook, Chair of the Taskforce for Lung Health.
Here, a leading clinical negligence specialist warns the UK may be heading for a “perfect storm” of diabetes complications, due to delayed COVID-19 referrals.
The Medicines Manufacturing Innovation Centre (MMIC) has developed a scalable, sustainable and more cost-effective way to manufacture oligonucleotides and treat rare diseases.
Anna Forsberg, Professor of Transplant Nursing at Lund University and Chair of the ETAHP Committee at the ESOT, explores a key area of development in heart transplant nursing as part of the build-up to ESOT Congress 2021.
![Figure 1: Sketch of the evolution of the Universe over the last 13.77 billion years. It started with the Big Bang, followed by an extremely short period of rapid exponential expansion. The furthest we can see is the cosmic microwave background, when radiation decoupled from matter, approximately 380,000 years after the Big Bang. This is followed by the ‘dark ages,’ during which this radiation redshifted from the visible regime into infrared and sub-mm wavelengths. The occurrence of the first stars, about 400 million years after the Big Bang, ended this phase, spearheading the formation of galaxies as we see them today. [Credit: NASA/WMAP Science Team, public domain]](https://www.openaccessgovernment.org/wp-content/uploads/2025/05/Fig-1_1200.jpg)
